In this section you can read all the latest news about counterfeit and substandard medicines from around Europe and the world.
EVENT POSTPONED: Patient safety and the implementation of the Falsified Medicines Directive in the hospital environment
The European Alliance for Access to Safe Medicines (EAASM) in collaboration with the European Union of Private Hospitals (UEHP) and the European Health Management Association
EVENT SUMMARY – Handling innovation in NANOMEDICINES: regulatory challenges and opportunities in modern healthcare
Event summary Handling Innovation in nanomedicines: regulatory changes needed to realise new treatment opportunities and ensure patient safety Science and technology have never moved as
Executive Summary Resources needed to implement the Falsified Medicines Directive in hospitals across the EU and the EEA would cost more than 86 million euros,